【摘要】 非ST段抬高急性冠状动脉综合征(non-ST-segment elevation acute coronary syndromes,NSTEACS)已成患者急诊和入院的主要原因,其抗血小板、抗凝、调脂、介入治疗等方面研究对提高患者的生存率及生存质量有重要意义。近年来,关于新的治疗药物、治疗方法的选择、介入治疗的时机及特殊人群的处理等方面都有一些新的进展。更多还原

【Abstract】 Non-ST-segment elevation acute coronary syndromes have become the main reason for emergency and admission,studies on the anti-platelet,anticoagulation,lipid-lowering and intervention are considered to be of utmost importance for the improvement of survival rates and quality of life of the patients.This article updates the developments in new drugs,treatment choices,the timing of intervention and treatments for special groups in recent years.更多还原